Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCAT2 | O15382 | 7/20 | 0.35 |
| ▸ | BCAT1 | P54687 | 7/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.32 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.32 |
| ▸ | ABCC9 | O60706 | 1/20 | 0.31 |
| ▸ | ABCC8 | Q09428 | 1/20 | 0.31 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.31 |
| ▸ | KCNJ8 | Q15842 | 1/20 | 0.31 |
| ▸ | AR | P10275 | 5/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7212890 | 0.83 | PGR (0.39) | BCAT2BCAT1AR | |
| SCHEMBL8323113 | 0.82 | PGR (0.35) | BCAT2BCAT1AR | |
| SCHEMBL8853791 | 0.82 | BCAT2 (0.35) | BCAT2BCAT1 | |
| SCHEMBL8193759 | 0.82 | BCAT2 (0.40) | BCAT2BCAT1AR | |
| SCHEMBL6743751 | 0.82 | BCAT2 (0.38) | BCAT2BCAT1AR | |
| SCHEMBL9469470 | 0.80 | BCAT2 (0.39) | BCAT2BCAT1GAAARMAPT | |
| SCHEMBL5848585 | 0.80 | BCAT1 (0.43) | BCAT2BCAT1 | |
| SCHEMBL8466083 | 0.80 | BCAT2 (0.34) | BCAT2BCAT1 | |
| SCHEMBL3901986 | 0.79 | BCAT2 (0.38) | BCAT2BCAT1 | |
| SCHEMBL8853375 | 0.79 | JAK2 (0.33) | BCAT2BCAT1AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6455697-B2 | Substituted phenyluracils | BAYER AKTIENGESELLSCHAFT (DE) | 2002-09-24 | — | — | US | disclosed |
| US-6437126-B1 | HERBICIDES; REACTING 1-(4-CYANO-2-FLUORO-5-FORMYL-PHENYL) -3,6-DIHYDRO-2,6-DIOXO-3-METHYL-4-TRIFLUOROMETHYL-1(2H)-PYRIMIDINE WITH METHYOXYAMINE, AN AMINE, MERCAPTAN, OR AN ALCOHOL | BAYER AKTIENGESELLSCHAFT (DE) | 2002-08-20 | — | — | US | disclosed |
| US-6251828-B1 | HERBICIDE FOR TOTAL CONTROL OF WEEDS | BAYER AKTIENGESELLSCHAFT (DE) | 2001-06-26 | — | — | US | disclosed |
| US-20010003732-A1 | 1-(4-cyano-2-fluoro-5-(2-chloro-2-methoxycarbonylethyl) -phenyl)-3,6-dihydro-2,6-dioxo-3-methyl-4-trifluoromethyl-1-(2H)-pyrimidine, for example; use as herbicides; chemical intermediates and method of synthesis | ANDREE ROLAND (DE) | 2001-06-14 | — | — | US | disclosed |
| US-6245714-B1 | HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2001-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010003732-A1 | 1-(4-cyano-2-fluoro-5-(2-chloro-2-methoxycarbonylethyl) -phenyl)-3,6-dihydro-2,6-dioxo-3-methyl-4-trifluoromethyl-1-(2H)-pyrimidine, for example; use as herbicides; chemical intermediates and method of synthesis | DDT, DPYD, DHFR | BCAT2 625/4885BCAT1 775/4885GAA 2169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.